- Latest News
Dr. Yuk-Ching Tse-Dinh's research investigates the structure and function of DNA topoisomerases as the basis of discovery for antibacterial and anticancer drug leads from synthetic molecules and natural products. With her grant renewal she will continue to focus on understanding the structure, mechanism, interactions and regulation of bacterial topoisomerase I, a validated target for discovery of novel antibacterial compounds.
The College of Arts, Sciences & Education recently featured biochemistry associate professor Yuan Liu for her research to help destroy Glioblastoma, a deadly brain cancer with no known cure. She is part of a team working in FIU's Biomolecular Sciences Institute.
What’s the future of personal mosquito protection? It may a combination of making ourselves invisible and disguising through a life saving perfume. Mosquito neuroscientist Matthew DeGennaro explains how he is using genetics to find a life saving perfume
BSI researcher, Dr. Fenfei Leng, is fighting antibiotic resistance, one of the most serious health problems in the US and also in the world, by developing novel high throughput screening assays to discover new types of antibiotics from the millions of compounds found in small molecule libraries.
Two grants totaling more than $3.1 million are helping researchers at FIU’s Biomolecular Sciences Institute wage war against Zika and malaria.
This summer the NSF awarded a 3-year $650,000 grant to FIU investigator Laura Serbus, an assistant professor in the Department of Biological Sciences and member of the Biomolecular Sciences Institute.
Dr. Helen Tempest will be honored as the recipient of the 2017 Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for her research in genetic basis for male infertility.
Dr. Jun Li's research aims to identify additional new proteins and targets them with multiple small molecules to stop malaria transmission.
By exploiting a brain tumor’s own biology, researchers at FIU’s Biomolecular Sciences Institute (BSI) are hoping to destroy glioblastoma, a deadly brain cancer with no known cure.
Dr. Miguel A. Villalona-Calero, BSI affiliated faculty member, has been named a Continuing Umbrella of Research Experiences (CURE) Lifetime Achievement Honoree.